1 – 50 of 145
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The human melanoma proteome atlas-Defining the molecular pathology
(
- Contribution to journal › Article
-
Mark
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome
(
- Contribution to journal › Article
-
Mark
Deep proteomic analysis on biobanked paraffine-archived melanoma with prognostic/predictive biomarker read-out
(
- Contribution to journal › Article
- 2020
-
Mark
Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
(
- Contribution to journal › Scientific review
-
Mark
Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
(
- Contribution to journal › Article
- 2019
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
(
- Contribution to journal › Article
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
(
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
(
- Contribution to journal › Article
- 2018
-
Mark
Inhibition of integrin αvβ6 changes fibril thickness of stromal collagen in experimental carcinomas
(
- Contribution to journal › Article
-
Mark
Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
(
- Contribution to journal › Article
- 2017
-
Mark
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
(
- Contribution to journal › Article
- 2016
-
Mark
Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma
(
- Contribution to journal › Article
-
Mark
The fetal thymus has a unique genomic copy number profile resulting from physiological T cell receptor gene rearrangement
(
- Contribution to journal › Article
- 2015
-
Mark
Drug Compound Characterization by Mass Spectrometry Imaging in Cancer Tissue
(
- Contribution to journal › Scientific review
-
Mark
Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
(
- Contribution to journal › Article
-
Mark
A protein deep sequencing evaluation of metastatic melanoma tissues.
(
- Contribution to journal › Article
- 2014
-
Mark
Heterogenous mismatch-repair status in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Feasibility Study on Measuring Selected Proteins in Malignant Melanoma Tissue by SRM Quantification.
(
- Contribution to journal › Article
-
Mark
Analysis of Alpha-Synuclein in Malignant Melanoma - Development of a SRM Quantification Assay.
(
- Contribution to journal › Article
-
Mark
A New Look at Drugs Targeting Malignant Melanoma – An Application for Mass Spectrometry Imaging
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability
(
- Contribution to journal › Article
-
Mark
Primary breast cancer tumours contain high amounts of IgA1 immunoglobulin: an immunohistochemical analysis of a possible carrier of the tumour-associated tn antigen.
(
- Contribution to journal › Article
-
Mark
Whole chromosome gain does not in itself confer cancer-like chromosomal instability.
(
- Contribution to journal › Article
-
Mark
Local inhibition of ornithine decarboxylase reduces vascular stenosis in a murine model of carotid injury
(
- Contribution to journal › Article
-
Mark
Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
(
- Contribution to journal › Article
- 2012
-
Mark
Photon activation therapy of RG2 glioma carrying Fischer rats using stable thallium and monochromatic synchrotron radiation.
(
- Contribution to journal › Article
-
Mark
Prognostic value of proliferation in pleomorphic soft tissue sarcomas: a new look at an old measure.
2012) In Human Pathology(
- Contribution to journal › Article
- 2011
-
Mark
A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti tumour activity.
(
- Contribution to journal › Article
-
Mark
Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer
(
- Contribution to journal › Article
-
Mark
The GPER1 Agonist G-1 Attenuates Endothelial Cell Proliferation by Inhibiting DNA Synthesis and Accumulating Cells in the S and G2 Phases of the Cell Cycle.
(
- Contribution to journal › Article
-
Mark
Challenges in the Identification of MSH6-Associated Colorectal Cancer: Rectal Location, Less Typical Histology, and a Subset With Retained Mismatch Repair Function.
(
- Contribution to journal › Article
- 2010
-
Mark
Analysis of protein expression in pure cell nuclei populations isolated from human breast cancer tissue by DNA flow cytometric sorting.
(
- Contribution to journal › Article
-
Mark
Early Metabolic Flare in Squamous Cell Carcinoma after Chemotherapy is a Marker of Treatment Sensitivity In Vitro
(
- Contribution to journal › Article
- 2009
-
Mark
Polyamine synthesis inhibition induces S phase cell cycle arrest in vascular smooth muscle cells.
(
- Contribution to journal › Article
-
Mark
Expression of Helix pomatia Lectin Binding Glycoproteins in Women with Breast Cancer in Relationship to Their Mood Group Phenotypes
(
- Contribution to journal › Article
-
Mark
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
(
- Contribution to journal › Article
- 2008
-
Mark
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.
(
- Contribution to journal › Article
- 2007
-
Mark
Combined flow cytometry and confocal laser scanning microscopy for evaluation of BR96 antibody cancer cell targeting and internalization.
(
- Contribution to journal › Article
-
Mark
Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1.
(
- Contribution to journal › Article
-
Mark
Regression analysis and modelling of data acquisition for SELDI-TOF mass spectrometry.
(
- Contribution to journal › Article
-
Mark
In-Source Decay Causes Artifacts in SELDI-TOF MS Spectra.
(
- Contribution to journal › Article
-
Mark
Serum protein profiling of metastatic breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Antibody microarray based oncoproteomics - analysis of breast cancer proteomes
(
- Contribution to journal › Published meeting abstract
- 2006
-
Mark
p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
(
- Contribution to journal › Article
-
Mark
Antibody microarray based oncoproteomics - analysis of breast cancer proteomes
2006) 29th annual San Antonio breast cancer symposium In Proceedings of the 29th annual San Antonio breast cancer symposium(
- Contribution to journal › Published meeting abstract
- 2004
-
Mark
Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck
(
- Contribution to journal › Article
-
Mark
Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.
(
- Contribution to journal › Article
-
Mark
A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer
(
- Contribution to journal › Article
-
Mark
Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a).
(
- Contribution to journal › Article
-
Mark
DNA ploidy, S-phase fraction and associations with 2-18F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma.
(
- Contribution to journal › Article